Tools
Tools
Stewart, Carrie, Gallacher, Katie, Nakham, Athagran, Cruickshank, Moira, Newlands, Rumana, Bond, Christine, Myint, Phyo Kyaw, Bhattacharya, Debi 
ORCID: https://orcid.org/0000-0003-3024-7453 and Mair, Frances S.
(2021)
Barriers and facilitators to reducing anticholinergic burden: A qualitative systematic review.
International Journal of Clinical Pharmacy, 43 (6).
1451–1460.
ISSN 2210-7703
Preview |
PDF (Published_Version)
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
Background: Despite common use, anticholinergic medications have been associated with serious health risks. Interventions to reduce their use are being developed and there is a need to understand their implementation into clinical care. Aim of review: This systematic review aims to identify and analyse qualitative research studies exploring the barriers and facilitators to reducing anticholinergic burden. Methods: Medline (OVID), EMBASE (OVID), CINAHL (EMBSCO) and PsycINFO (OVID) were searched using comprehensive search terms. Peer reviewed studies published in English presenting qualitative research in relation to the barriers and facilitators of deprescribing anticholinergic medications, involving patients, carers or health professionals were eligible. Normalization Process Theory was used to explore and explain the data. Results: Of 1764 identified studies, two were eligible and both involved healthcare professionals (23 general practitioners, 13 specialist clinicians and 12 pharmacists). No studies were identified that involved patients or carers. Barriers to collaborative working often resulted in poor motivation to reduce anticholinergic use. Low confidence, system resources and organisation of care also hindered anticholinergic burden reduction. Good communication and relationships with patients, carers and other healthcare professionals were reported as important for successful anticholinergic burden reduction. Having a named person for prescribing decisions, and clear role boundaries, were also important facilitators. Conclusions: This review identified important barriers and facilitators to anticholinergic burden reduction from healthcare provider perspectives which can inform implementation of such deprescribing interventions. Studies exploring patient and carer perspectives are presently absent but are required to ensure person-centeredness and feasibility of future interventions.
| Item Type: | Article |
|---|---|
| Additional Information: | Availability of data and materials: No additional unpublished data are available. Funding information: This study is funded by The Dunhill Medical Trust (RPGF1806/66) as part of a series of work building an evidence synthesis suite to inform a future randomised trial of reducing anticholinergic related harm in older adults. The funding sponsors had no role in the design, execution, interpretation or writing of the study. |
| Uncontrolled Keywords: | anticholinergics,deprescribing,intervention implementation,qualitative research,systematic review,pharmacy,toxicology,pharmacology,pharmaceutical science,pharmacology (medical),sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/3600/3611 |
| Faculty \ School: | Faculty of Science > School of Pharmacy (former - to 2024) Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Science > Research Groups > Patient Care |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 23 Jul 2021 00:20 |
| Last Modified: | 25 Oct 2024 23:55 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/80718 |
| DOI: | 10.1007/s11096-021-01293-4 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |